Updated on 2025/05/15

写真a

 
Keisuke Hamada
 
Organization
Graduate School of Medicine Department of Medicine Biochemistry Assistant Professor
School of Medicine Medical Course
Title
Assistant Professor
Profile
奈良先端科学技術大学院大学バイオサイエンス研究科博士後期課程修了後、理化学研究所での博士研究員を経て、現職。専門は構造生物学。
External link

Research Interests

  • X線結晶構造解析

  • 構造生物学

Research Areas

  • Life Science / Structural biochemistry

Education

  • Nara Institute of Science and Technology   Graduate School, Division of Biological Science   Division of Cell Biology

    - 2001

      More details

  • Nara Institute of Science and Technology   Graduate School of Biological Sciences

    1996 - 2001

      More details

    Country: Japan

    researchmap

Research History

  • Yokohama City University   Assistant Professor

    2004.4

      More details

  • 理化学研究所基礎科学特別研究員

    2001.4 - 2004.3

      More details

  • 日本学術振興会特別研究員(DC2)

    1999.1 - 2001.3

      More details

Professional Memberships

Papers

  • Hemizygous SMARCA1 variants cause X-linked intellectual disability. Reviewed International journal

    Naoto Nishimura, Takeshi Mizuguchi, Keisuke Hamada, Kotaro Yuge, Masamune Sakamoto, Naomi Tsuchida, Yuri Uchiyama, Atsushi Fujita, Eriko Koshimizu, Kazuharu Misawa, Satoko Miyatake, Yoriko Watanabe, Hitoshi Osaka, Koh-Ichiro Yoshiura, Kazuhiro Ogata, Naomichi Matsumoto

    Journal of human genetics   2025.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Pathogenic SNF2 related chromatin remodeling ATPase 1 (SMARCA1) variants have been reported in patients with X-linked intellectual disability (XLID) characterized by macrocephaly and variable neurological symptoms. Here, we report two unrelated male patients with XLID due to novel SMARCA1 variants detected by exome sequencing. Patient 1 showed macrocephaly, behavioral difficulty, and learning disability with a hemizygous SMARCA1 variant (NM_003069.5:c.1795 C > T p.[Gln599*]) leading to nonsense-mediated decay. Patient 2 had ataxia and speech delay with a hemizygous missense variant (NM_003069.5:c.1343 G > T p.[Arg448Leu]). Structural modeling suggested that the missense variant, p.(Arg448Leu) might destabilize interactions between SMARCA1 and nucleosomal DNA, thereby contributing to the abberant effect of mutant SMARCA1 protein. Both variants were inherited from their unaffected healthy mothers. This study suggests that hemizygous variants impairing SMARCA1 function can cause XLID with other variable features, such as macrocephaly and ataxia, in men.

    DOI: 10.1038/s10038-025-01346-w

    PubMed

    researchmap

  • A p.N92K variant of the GTPase RAC3 disrupts cortical neuron migration and axon elongation. Reviewed International journal

    Ryota Sugawara, Keisuke Hamada, Hidenori Ito, Marcello Scala, Hiroshi Ueda, Hidenori Tabata, Kazuhiro Ogata, Koh-Ichi Nagata

    The Journal of biological chemistry   108346 - 108346   2025.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    RAC3 encodes a small GTPase of the Rho family, crucial for actin cytoskeleton organization and signaling pathways. De novo deleterious variants in RAC3 cause neurodevelopmental disorder with structural brain anomalies and dysmorphic facies (NEDBAF). Disease-causing variants thus far reported are thought to impact key conserved regions within RAC3, such as the P-loop, switch I/II, and G boxes, which are essential for the interaction with regulatory proteins and effectors. Recently, however, a novel variant, c.276T>A, p.N92K, was identified in a prenatal case with complex brain malformations. This variant, located outside the core functional regions, represents a unique class of RAC3 pathogenic mutations. We investigated the variant's effects using in vitro, in silico, and in vivo approaches. Overexpression of RAC3-N92K in primary hippocampal neurons impaired differentiation, leading to round cell shape with lamellipodia, suggesting that RAC3-N92K is active. Biochemical studies showed that RAC3-N92K is 1) resistant to GAP-mediated inactivation, 2) responsive to GEF activation, and 3) capable of interacting with RAC effectors PAK1 and MLK2, as well as Rho-kinase 1, activating gene expression through SRF, NFκB, and AP1 pathways. Structural analyses suggest that N92K disrupts GAP interactions but preserves interactions with GEF, PAK1, and MLK2. In vivo, RAC3-N92K expression in embryonic mouse cortical neurons led to migration defects and periventricular clustering during corticogenesis, along with impaired axon elongation. These findings indicate that RAC3-N92K's activated state significantly disrupts cortical development, expanding the genetic and pathophysiological spectrum of NEDBAF.

    DOI: 10.1016/j.jbc.2025.108346

    PubMed

    researchmap

  • Biallelic missense CEP55 variants cause prenatal MARCH syndrome. Reviewed International journal

    Li Fu, Yuka Yamamoto, Rie Seyama, Nana Matsuzawa, Mariko Nagaoka, Takashi Yao, Keisuke Hamada, Kazuhiro Ogata, Toshifumi Suzuki, Naomi Tsuchida, Yuri Uchiyama, Eriko Koshimizu, Kazuharu Misawa, Satoko Miyatake, Takeshi Mizuguchi, Atsushi Fujita, Atsuo Itakura, Naomichi Matsumoto

    Journal of human genetics   2024.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    CEP55 encodes centrosomal protein 55 kDa, which plays a crucial role in mitosis, particularly cytokinesis. Biallelic CEP55 variants cause MARCH syndrome (multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly). Here, we describe a Japanese family with two affected siblings harboring novel compound heterozygous CEP55 variants, NM_001127182: c.[1357 C > T];[1358 G > A] p.[(Arg453Cys)];[(Arg453His)]. Both presented clinically with typical lethal MARCH syndrome. Although a combination of missense and nonsense variants has been reported previously, this is the first report of biallelic missense CEP55 variants. These variants biallelically affected the same amino acid, Arg453, in the last 40 amino acids of CEP55. These residues are functionally important for CEP55 localization to the midbody during cell division, and may be associated with severe clinical outcomes. More cases of pathogenic CEP55 variants are needed to establish the genotype-phenotype correlation.

    DOI: 10.1038/s10038-024-01298-7

    PubMed

    researchmap

  • De Novo Discovery of Pseudo-Natural Prenylated Macrocyclic Peptide Ligands. Reviewed International journal

    Sumika Inoue, Dinh Thanh Nguyen, Keisuke Hamada, Rika Okuma, Chikako Okada, Masahiro Okada, Ikuro Abe, Toru Sengoku, Yuki Goto, Hiroaki Suga

    Angewandte Chemie (International ed. in English)   e202409973   2024.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Prenylation of peptides is widely observed in the secondary metabolites of diverse organisms, granting peptides unique chemical properties distinct from proteinogenic amino acids. Discovery of prenylated peptide agents has largely relied on isolation or genome mining of naturally occurring molecules. To devise a platform technology for de novo discovery of artificial prenylated peptides targeting a protein of choice, here we have integrated the thioether-macrocyclic peptide (teMP) library construction/selection technology, so-called RaPID (Random nonstandard Peptides Integrated Discovery) system, with a Trp-C3-prenyltransferase KgpF involved in the biosynthesis of a prenylated natural product. This unique enzyme exhibited remarkably broad substrate tolerance, capable of modifying various Trp-containing teMPs to install a prenylated residue with tricyclic constrained structure. We constructed a vast library of prenylated teMPs and subjected it to in vitro selection against a phosphoglycerate mutase. This selection platform has led to the identification of a pseudo-natural prenylated teMP inhibiting the target enzyme with an IC50 of 30 nM. Importantly, the prenylation was essential for the inhibitory activity, enhanced serum stability, and cellular uptake of the peptide, highlighting the benefits of peptide prenylation. This work showcases the de novo discovery platform for pseudo-natural prenylated peptides, which is readily applicable to other drug targets.

    DOI: 10.1002/anie.202409973

    PubMed

    researchmap

  • A Compact Reprogrammed Genetic Code for De Novo Discovery of Proteolytically Stable Thiopeptides. Reviewed International journal

    Alexander A Vinogradov, Yue Zhang, Keisuke Hamada, Shunsuke Kobayashi, Kazuhiro Ogata, Toru Sengoku, Yuki Goto, Hiroaki Suga

    Journal of the American Chemical Society   146 ( 12 )   8058 - 8070   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Thiopeptides make up a group of structurally complex peptidic natural products holding promise in bioengineering applications. The previously established thiopeptide/mRNA display platform enables de novo discovery of natural product-like thiopeptides with designed bioactivities. However, in contrast to natural thiopeptides, the discovered structures are composed predominantly of proteinogenic amino acids, which results in low metabolic stability in many cases. Here, we redevelop the platform and demonstrate that the utilization of compact reprogrammed genetic codes in mRNA display libraries can lead to the discovery of thiopeptides predominantly composed of nonproteinogenic structural elements. We demonstrate the feasibility of our designs by conducting affinity selections against Traf2- and NCK-interacting kinase (TNIK). The experiment identified a series of thiopeptides with high affinity to the target protein (the best KD = 2.1 nM) and kinase inhibitory activity (the best IC50 = 0.15 μM). The discovered compounds, which bore as many as 15 nonproteinogenic amino acids in an 18-residue macrocycle, demonstrated high metabolic stability in human serum with a half-life of up to 99 h. An X-ray cocrystal structure of TNIK in complex with a discovered thiopeptide revealed how nonproteinogenic building blocks facilitate the target engagement and orchestrate the folding of the thiopeptide into a noncanonical conformation. Altogether, the established platform takes a step toward the discovery of thiopeptides with high metabolic stability for early drug discovery applications.

    DOI: 10.1021/jacs.3c12037

    PubMed

    researchmap

  • Structure of the human Bre1 complex bound to the nucleosome. Reviewed International journal

    Shuhei Onishi, Kotone Uchiyama, Ko Sato, Chikako Okada, Shunsuke Kobayashi, Keisuke Hamada, Tomohiro Nishizawa, Osamu Nureki, Kazuhiro Ogata, Toru Sengoku

    Nature communications   15 ( 1 )   2580 - 2580   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Histone H2B monoubiquitination (at Lys120 in humans) regulates transcription elongation and DNA repair. In humans, H2B monoubiquitination is catalyzed by the heterodimeric Bre1 complex composed of Bre1A/RNF20 and Bre1B/RNF40. The Bre1 proteins generally function as tumor suppressors, while in certain cancers, they facilitate cancer cell proliferation. To obtain structural insights of H2BK120 ubiquitination and its regulation, we report the cryo-electron microscopy structure of the human Bre1 complex bound to the nucleosome. The two RING domains of Bre1A and Bre1B recognize the acidic patch and the nucleosomal DNA phosphates around SHL 6.0-6.5, which are ideally located to recruit the E2 enzyme and ubiquitin for H2BK120-specific ubiquitination. Mutational experiments suggest that the two RING domains bind in two orientations and that ubiquitination occurs when Bre1A binds to the acidic patch. Our results provide insights into the H2BK120-specific ubiquitination by the Bre1 proteins and suggest that H2B monoubiquitination can be regulated by nuclesomal DNA flexibility.

    DOI: 10.1038/s41467-024-46910-8

    PubMed

    researchmap

  • Novel missense variants cause intermediate phenotypes in the phenotypic spectrum of SLC5A6-related disorders Reviewed

    Yasuhiro Utsuno, Keisuke Hamada, Kohei Hamanaka, Keita Miyoshi, Keiji Tsuchimoto, Satoshi Sunada, Toshiyuki Itai, Masamune Sakamoto, Naomi Tsuchida, Yuri Uchiyama, Eriko Koshimizu, Atsushi Fujita, Satoko Miyatake, Kazuharu Misawa, Takeshi Mizuguchi, Yasuhito Kato, Kuniaki Saito, Kazuhiro Ogata, Naomichi Matsumoto

    Journal of Human Genetics   69 ( 2 )   69 - 77   2023.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1038/s10038-023-01206-5

    PubMed

    researchmap

    Other Link: https://www.nature.com/articles/s10038-023-01206-5

  • Switching Prenyl Donor Specificities of Cyanobactin Prenyltransferases Reviewed

    Yuchen Zhang, Keisuke Hamada, Masayuki Satake, Toru Sengoku, Yuki Goto, Hiroaki Suga

    Journal of the American Chemical Society   2023.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/jacs.3c07373

    researchmap

  • Stretch-activated ion channel TMEM63B associates with developmental and epileptic encephalopathies and progressive neurodegeneration Reviewed

    Annalisa Vetro, Cristiana Pelorosso, Simona Balestrini, Alessio Masi, Sophie Hambleton, Emanuela Argilli, Valerio Conti, Simone Giubbolini, Rebekah Barrick, Gaber Bergant, Karin Writzl, Emilia K. Bijlsma, Theresa Brunet, Pilar Cacheiro, Davide Mei, Anita Devlin, Mariëtte J.V. Hoffer, Keren Machol, Guido Mannaioni, Masamune Sakamoto, Manoj P. Menezes, Thomas Courtin, Elliott Sherr, Riccardo Parra, Ruth Richardson, Tony Roscioli, Marcello Scala, Celina von Stülpnagel, Damian Smedley, Annalaura Torella, Jun Tohyama, Reiko Koichihara, Keisuke Hamada, Kazuhiro Ogata, Takashi Suzuki, Atsushi Sugie, Jasper J. van der Smagt, Koen van Gassen, Stephanie Valence, Emma Vittery, Stephen Malone, Mitsuhiro Kato, Naomichi Matsumoto, Gian Michele Ratto, Renzo Guerrini, Francesca Pochiero, Francesco Mari, Venkateswaran Ramesh, Valeria Capra, Margherita Mancardi, Boris Keren, Cyiril Mignot, Matteo Lulli, Kendall Parks, Helen Griffin, Melanie Brugger, Vincenzo Nigro, Yuko Hirata, Reiko Koichihara, Borut Peterlin, Yuko Hirata, Ryuto Maki, Yohei Nitta, John C. Ambrose, Prabhu Arumugam, Roel Bevers, Marta Bleda, Freya Boardman-Pretty, Christopher R. Boustred, Helen Brittain, Matthew A. Brown, Mark J. Caulfield, Georgia C. Chan, Adam Giess, John N. Griffin, Angela Hamblin, Shirley Henderson, Tim J.P. Hubbard, Rob Jackson, Louise J. Jones, Dalia Kasperaviciute, Melis Kayikci, Athanasios Kousathanas, Lea Lahnstein, Anna Lakey, Sarah E.A. Leigh, Ivonne U.S. Leong, Javier F. Lopez, Fiona Maleady-Crowe, Meriel McEntagart, Federico Minneci, Jonathan Mitchell, Loukas Moutsianas, Michael Mueller, Nirupa Murugaesu, Anna C. Need, Peter O’Donovan, Chris A. Odhams, Christine Patch, Daniel Perez-Gil, Marina B. Pereira, John Pullinger, Tahrima Rahim, Augusto Rendon, Tim Rogers, Kevin Savage, Kushmita Sawant, Richard H. Scott, Afshan Siddiq, Alexander Sieghart, Samuel C. Smith, Alona Sosinsky, Alexander Stuckey, Mélanie Tanguy, Ana Lisa Taylor Tavares, Ellen R.A. Thomas, Simon R. Thompson, Arianna Tucci, Matthew J. Welland, Eleanor Williams, Katarzyna Witkowska, Suzanne M. Wood, Magdalena Zarowiecki

    The American Journal of Human Genetics   110 ( 8 )   1356 - 1376   2023.8

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.ajhg.2023.06.008

    researchmap

  • A missense variant at the RAC1-PAK1 binding site of RAC1 inactivates downstream signaling in VACTERL association Reviewed

    Rie Seyama, Masashi Nishikawa, Yuri Uchiyama, Keisuke Hamada, Yuka Yamamoto, Masahiro Takeda, Takanori Ochi, Monami Kishi, Toshifumi Suzuki, Kohei Hamanaka, Atsushi Fujita, Naomi Tsuchida, Eriko Koshimizu, Kazuharu Misawa, Satoko Miyatake, Takeshi Mizuguchi, Shintaro Makino, Takashi Yao, Hidenori Ito, Atsuo Itakura, Kazuhiro Ogata, Koh-ichi Nagata, Naomichi Matsumoto

    Scientific Reports   13 ( 1 )   2023.6

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Abstract

    RAC1 at 7p22.1 encodes a RAC family small GTPase that regulates actin cytoskeleton organization and intracellular signaling pathways. Pathogenic RAC1 variants result in developmental delay and multiple anomalies. Here, exome sequencing identified a rare de novo RAC1 variant [NM_018890.4:c.118T > C p.(Tyr40His)] in a male patient. Fetal ultrasonography indicated the patient to have multiple anomalies, including persistent left superior vena cava, total anomalous pulmonary venous return, esophageal atresia, scoliosis, and right-hand polydactyly. After birth, craniofacial dysmorphism and esophagobronchial fistula were confirmed and VACTERL association was suspected. One day after birth, the patient died of respiratory failure caused by tracheal aplasia type III. The molecular mechanisms of pathogenic RAC1 variants remain largely unclear; therefore, we biochemically examined the pathophysiological significance of RAC1-p.Tyr40His by focusing on the best characterized downstream effector of RAC1, PAK1, which activates Hedgehog signaling. RAC1-p.Tyr40His interacted minimally with PAK1, and did not enable PAK1 activation. Variants in the RAC1 Switch II region consistently activate downstream signals, whereas the p.Tyr40His variant at the RAC1-PAK1 binding site and adjacent to the Switch I region may deactivate the signals. It is important to accumulate data from individuals with different RAC1 variants to gain a full understanding of their varied clinical presentations.

    DOI: 10.1038/s41598-023-36381-0

    researchmap

    Other Link: https://www.nature.com/articles/s41598-023-36381-0

  • Three KINSSHIP syndrome patients with mosaic and germline AFF3 variants Reviewed International journal

    Yuta Inoue, Naomi Tsuchida, Nobuhiko Okamoto, Shimakawa Shuichi, Kei Ohashi, Shinji Saitoh, Atsushi Ogawa, Keisuke Hamada, Masamune Sakamoto, Noriko Miyake, Kohei Hamanaka, Atsushi Fujita, Eriko Koshimizu, Satoko Miyatake, Takeshi Mizuguchi, Kazuhiro Ogata, Yuri Uchiyama, Naomichi Matsumoto

    Clinical Genetics   103 ( 5 )   590 - 595   2023.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    AFF3 at 2q11.2 encodes the nuclear transcriptional activator AF4/FMR2 Family Member 3. AFF3 constitutes super elongation complex like 3, which plays a role in promoting the expression of genes involved in neurogenesis and development. The degron motif in AFF3 with nine highly conserved amino acids is recognized by E3 ubiquitin ligase to induce protein degradation. Recently, AFF3 missense variants in this region and variants featuring deletion including this region were identified and shown to cause KINSSHIP syndrome. In this study, we identified two novel and one previously reported missense variants in the degron of AFF3 in three unrelated Japanese patients. Notably, two of these three variants exhibited mosaicism in the examined tissues. This study suggests that mosaic variants also cause KINSSHIP syndrome, showing various phenotypes.

    DOI: 10.1111/cge.14292

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/cge.14292

  • Structural basis of transcription regulation by CNC family transcription factor, Nrf2 Reviewed

    Toru Sengoku, Masaaki Shiina, Kae Suzuki, Keisuke Hamada, Ko Sato, Akiko Uchiyama, Shunsuke Kobayashi, Asako Oguni, Hayato Itaya, Kota Kasahara, Hirotomo Moriwaki, Chiduru Watanabe, Teruki Honma, Chikako Okada, Shiho Baba, Tsutomu Ohta, Hozumi Motohashi, Masayuki Yamamoto, Kazuhiro Ogata

    Nucleic Acids Research   50 ( 21 )   12543 - 12557   2022.12

     More details

    Publishing type:Research paper (scientific journal)   Publisher:Oxford University Press (OUP)  

    Abstract

    Several basic leucine zipper (bZIP) transcription factors have accessory motifs in their DNA-binding domains, such as the CNC motif of CNC family or the EHR motif of small Maf (sMaf) proteins. CNC family proteins heterodimerize with sMaf proteins to recognize CNC–sMaf binding DNA elements (CsMBEs) in competition with sMaf homodimers, but the functional role of the CNC motif remains elusive. In this study, we report the crystal structures of Nrf2/NFE2L2, a CNC family protein regulating anti-stress transcriptional responses, in a complex with MafG and CsMBE. The CNC motif restricts the conformations of crucial Arg residues in the basic region, which form extensive contact with the DNA backbone phosphates. Accordingly, the Nrf2–MafG heterodimer has approximately a 200-fold stronger affinity for CsMBE than canonical bZIP proteins, such as AP-1 proteins. The high DNA affinity of the CNC–sMaf heterodimer may allow it to compete with the sMaf homodimer on target genes without being perturbed by other low-affinity bZIP proteins with similar sequence specificity.

    DOI: 10.1093/nar/gkac1102

    researchmap

  • De Novo Discovery of Thiopeptide Pseudo-natural Products Acting as Potent and Selective TNIK Kinase Inhibitors Reviewed

    Alexander A. Vinogradov, Yue Zhang, Keisuke Hamada, Jun Shi Chang, Chikako Okada, Hirotaka Nishimura, Naohiro Terasaka, Yuki Goto, Kazuhiro Ogata, Toru Sengoku, Hiroyasu Onaka, Hiroaki Suga

    Journal of the American Chemical Society   144 ( 44 )   20332 - 20341   2022.11

     More details

    Publishing type:Research paper (scientific journal)   Publisher:American Chemical Society (ACS)  

    DOI: 10.1021/jacs.2c07937

    researchmap

  • LimF is a versatile prenyltransferase for histidine-C-geranylation on diverse non-natural substrates Reviewed

    Yuchen Zhang, Keisuke Hamada, Dinh Thanh Nguyen, Sumika Inoue, Masayuki Satake, Shunsuke Kobayashi, Chikako Okada, Kazuhiro Ogata, Masahiro Okada, Toru Sengoku, Yuki Goto, Hiroaki Suga

    Nature Catalysis   5 ( 8 )   682 - 693   2022.8

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1038/s41929-022-00822-2

    researchmap

    Other Link: https://www.nature.com/articles/s41929-022-00822-2

  • Amelioration of a neurodevelopmental disorder by carbamazepine in a case having a gain-of-function GRIA3 variant Reviewed International journal

    Kohei Hamanaka, Keita Miyoshi, Jia-Hui Sun, Keisuke Hamada, Takao Komatsubara, Ken Saida, Naomi Tsuchida, Yuri Uchiyama, Atsushi Fujita, Takeshi Mizuguchi, Benedicte Gerard, Allan Bayat, Berardo Rinaldi, Mitsuhiro Kato, Jun Tohyama, Kazuhiro Ogata, Yun Stone Shi, Kuniaki Saito, Satoko Miyatake, Naomichi Matsumoto

    Human Genetics   141 ( 2 )   283 - 293   2022.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    GRIA3 at Xq25 encodes glutamate ionotropic receptor AMPA type 3 (GluA3), a subunit of postsynaptic glutamate-gated ion channels mediating neurotransmission. Hemizygous loss-of-function (LOF) variants in GRIA3 cause a neurodevelopmental disorder (NDD) in male individuals. Here, we report a gain-of-function (GOF) variant at GRIA3 in a male patient. We identified a hemizygous de novo missense variant in GRIA3 in a boy with an NDD: c.1844C > T (p.Ala615Val) using whole-exome sequencing. His neurological signs, such as hypertonia and hyperreflexia, were opposite to those in previous cases having LOF GRIA3 variants. His seizures and hypertonia were ameliorated by carbamazepine, inhibiting glutamate release from presynapses. Patch-clamp recordings showed that the human GluA3 mutant (p.Ala615Val) had slower desensitization and deactivation kinetics. A fly line expressing a human GluA3 mutant possessing our variant and the Lurcher variant, which makes ion channels leaky, showed developmental defects, while one expressing a mutant possessing either of them did not. Collectively, these results suggest that p.Ala615Val has GOF effects. GRIA3 GOF variants may cause an NDD phenotype distinctive from that of LOF variants, and drugs suppressing glutamatergic neurotransmission may ameliorate this phenotype. This study should help in refining the clinical management of GRIA3-related NDDs.

    DOI: 10.1007/s00439-021-02416-7

    PubMed

    researchmap

    Other Link: https://link.springer.com/article/10.1007/s00439-021-02416-7/fulltext.html

  • Structural basis of the regulation of the normal and oncogenic methylation of nucleosomal histone H3 Lys36 by NSD2. Reviewed International journal

    Ko Sato, Amarjeet Kumar, Keisuke Hamada, Chikako Okada, Asako Oguni, Ayumi Machiyama, Shun Sakuraba, Tomohiro Nishizawa, Osamu Nureki, Hidetoshi Kono, Kazuhiro Ogata, Toru Sengoku

    Nature communications   12 ( 1 )   6605 - 6605   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Dimethylated histone H3 Lys36 (H3K36me2) regulates gene expression, and aberrant H3K36me2 upregulation, resulting from either the overexpression or point mutation of the dimethyltransferase NSD2, is found in various cancers. Here we report the cryo-electron microscopy structure of NSD2 bound to the nucleosome. Nucleosomal DNA is partially unwrapped, facilitating NSD2 access to H3K36. NSD2 interacts with DNA and H2A along with H3. The NSD2 autoinhibitory loop changes its conformation upon nucleosome binding to accommodate H3 in its substrate-binding cleft. Kinetic analysis revealed that two oncogenic mutations, E1099K and T1150A, increase NSD2 catalytic turnover. Molecular dynamics simulations suggested that in both mutants, the autoinhibitory loop adopts an open state that can accommodate H3 more often than the wild-type. We propose that E1099K and T1150A destabilize the interactions that keep the autoinhibitory loop closed, thereby enhancing catalytic turnover. Our analyses guide the development of specific inhibitors of NSD2.

    DOI: 10.1038/s41467-021-26913-5

    PubMed

    researchmap

  • Two families with TET3-related disorder showing neurodevelopmental delay with craniofacial dysmorphisms. Reviewed International journal

    Rie Seyama, Naomi Tsuchida, Yasuyuki Okada, Sonoko Sakata, Keisuke Hamada, Yoshiteru Azuma, Kohei Hamanaka, Atsushi Fujita, Eriko Koshimizu, Satoko Miyatake, Takeshi Mizuguchi, Shintaro Makino, Atsuo Itakura, Satoshi Okada, Nobuhiko Okamoto, Kazuhiro Ogata, Yuri Uchiyama, Naomichi Matsumoto

    Journal of human genetics   67 ( 3 )   157 - 164   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    TET3 at 2p13.1 encodes tet methylcytosine dioxygenase 3, a demethylation enzyme that converts 5-methylcytosine to 5-hydroxymethylcytosine. Beck et al. reported that patients with TET3 abnormalities in either an autosomal dominant or recessive inheritance fashion clinically showed global developmental delay, intellectual disability, and dysmorphisms. In this study, exome sequencing identified both mono- and biallelic TET3 variants in two families: a de novo variant NM_001287491.1:c.3028 A > G:p.(Asn1010Asp), and compound heterozygous variants NM_001287491.1:c.[2077 C > T];[2896 T > G],p.[Gln693*];[Cys966Gly]. Despite the different inheritance modes, the affected individuals showed similar phenotypic features. Including these three patients, only 14 affected individuals have been reported to date. The accumulation of data regarding individuals with TET3-related disorder is necessary to describe their clinical spectrum.

    DOI: 10.1038/s10038-021-00986-y

    PubMed

    researchmap

  • De novo ATP1A3 variants cause polymicrogyria. Reviewed International journal

    Satoko Miyatake, Mitsuhiro Kato, Takuma Kumamoto, Tomonori Hirose, Eriko Koshimizu, Takaaki Matsui, Hideyuki Takeuchi, Hiroshi Doi, Keisuke Hamada, Mitsuko Nakashima, Kazunori Sasaki, Akio Yamashita, Atsushi Takata, Kohei Hamanaka, Mai Satoh, Takabumi Miyama, Yuri Sonoda, Momoko Sasazuki, Hiroyuki Torisu, Toshiro Hara, Yasunari Sakai, Yushi Noguchi, Mazumi Miura, Yoko Nishimura, Kazuyuki Nakamura, Hideyuki Asai, Nodoka Hinokuma, Fuyuki Miya, Tatsuhiko Tsunoda, Masami Togawa, Yukihiro Ikeda, Nobusuke Kimura, Kaoru Amemiya, Asako Horino, Masataka Fukuoka, Hiroko Ikeda, Goni Merhav, Nina Ekhilevitch, Masaki Miura, Takeshi Mizuguchi, Noriko Miyake, Atsushi Suzuki, Shouichi Ohga, Hirotomo Saitsu, Hidehisa Takahashi, Fumiaki Tanaka, Kazuhiro Ogata, Chiaki Ohtaka-Maruyama, Naomichi Matsumoto

    Science advances   7 ( 13 )   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Polymicrogyria is a common malformation of cortical development whose etiology remains elusive. We conducted whole-exome sequencing for 124 patients with polymicrogyria and identified de novo ATP1A3 variants in eight patients. Mutated ATP1A3 causes functional brain diseases, including alternating hemiplegia of childhood (AHC), rapid-onset dystonia parkinsonism (RDP), and cerebellar ataxia, areflexia, pes cavus, optic nerve atrophy, and sensorineural deafness (CAPOS). However, our patients showed no clinical features of AHC, RDP, or CAPOS and had a completely different phenotype: a severe form of polymicrogyria with epilepsy and developmental delay. Detected variants had different locations in ATP1A3 and different functional properties compared with AHC-, RDP-, or CAPOS-associated variants. In the developing cerebral cortex of mice, radial neuronal migration was impaired in neurons overexpressing the ATP1A3 variant of the most severe patients, suggesting that this variant is involved in cortical malformation pathogenesis. We propose a previously unidentified category of polymicrogyria associated with ATP1A3 abnormalities.

    DOI: 10.1126/sciadv.abd2368

    PubMed

    researchmap

  • GRIN2D variants in three cases of developmental and epileptic encephalopathy. Reviewed International journal

    Naomi Tsuchida, Keisuke Hamada, Masaaki Shiina, Mitsuhiro Kato, Yu Kobayashi, Jun Tohyama, Kazue Kimura, Kyoko Hoshino, Vigneswari Ganesan, Keng W Teik, Mitsuko Nakashima, Satomi Mitsuhashi, Takeshi Mizuguchi, Atsushi Takata, Noriko Miyake, Hirotomo Saitsu, Kazuhiro Ogata, Satoko Miyatake, Naomichi Matsumoto

    Clinical genetics   94 ( 6 )   538 - 547   2018.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    N-methyl-d-aspartate (NMDA) receptors are glutamate-activated ion channels that are widely distributed in the central nervous system and essential for brain development and function. Dysfunction of NMDA receptors has been associated with various neurodevelopmental disorders. Recently, a de novo recurrent GRIN2D missense variant was found in two unrelated patients with developmental and epileptic encephalopathy. In this study, we identified by whole exome sequencing novel heterozygous GRIN2D missense variants in three unrelated patients with severe developmental delay and intractable epilepsy. All altered residues were highly conserved across vertebrates and among the four GluN2 subunits. Structural consideration indicated that all three variants are probably to impair GluN2D function, either by affecting intersubunit interaction or altering channel gating activity. We assessed the clinical features of our three cases and compared them to those of the two previously reported GRIN2D variant cases, and found that they all show similar clinical features. This study provides further evidence of GRIN2D variants being causal for epilepsy. Genetic diagnosis for GluN2-related disorders may be clinically useful when considering drug therapy targeting NMDA receptors.

    DOI: 10.1111/cge.13454

    PubMed

    researchmap

  • A Novel Allosteric Mechanism on Protein-DNA Interactions underlying the Phosphorylation-Dependent Regulation of Ets1 Target Gene Expressions Reviewed

    Masaaki Shiina, Keisuke Hamada, Taiko Inoue-Bungo, Mariko Shimamura, Akiko Uchiyama, Shiho Baba, Ko Sato, Masaki Yamamoto, Kazuhiro Ogata

    JOURNAL OF MOLECULAR BIOLOGY   427 ( 8 )   1655 - 1669   2015.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD  

    Cooperative assemblies of transcription factors (TFs) on target gene enhancers coordinate cell proliferation, fate specification, and differentiation through precise and complicated transcriptional mechanisms. Chemical modifications, such as phosphorylation, of TFs induced by cell signaling further modulate the dynamic cooperativity of TFs. In this study, we found that various Ets1-containing TF-DNA complexes respond differently to calcium-induced phosphorylation of Ets1, which is known to inhibit Ets1 DNA binding. Crystallographic analysis of a complex comprising Ets1, Runx1, and CBF beta at the TCR alpha enhancer revealed that Ets1 acquires robust binding stability in the Runx1 and DNA-complexed state, via allosteric mechanisms. This allows phosphorylated Ets1 to be retained at the TCRa enhancer with Runx1, in contrast to other Ets1 target gene enhancers including mb-1 and stromelysin-1. This study provides a structure-based model for cell-signaling-dependent regulation of target genes, mediated via chemical modification of TFs. (C) 2014 The Authors. Published by Elsevier Ltd.

    DOI: 10.1016/j.jmb.2014.07.020

    Web of Science

    PubMed

    researchmap

  • Crystallization of the Ets1-Runx1-CBF beta-DNA complex formed on the TCR alpha gene enhancer Reviewed

    Masaaki Shiina, Keisuke Hamada, Taiko Inoue-Bungo, Mariko Shimamura, Shiho Baba, Ko Sato, Kazuhiro Ogata

    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS   70 ( Pt 10 )   1380 - 1384   2014.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Gene transcription is regulated in part through the assembly of multiple transcription factors (TFs) on gene enhancers. To enable examination of the mechanism underlying the formation of these complexes and their response to a phosphorylation signal, two kinds of higher-order TF-DNA assemblies were crystallized composed of an unmodified or phosphorylated Ets1 fragment, a Runx1(L94K) fragment and a CBF beta fragment on the T-cell receptor (TCR) alpha gene enhancer. Within these complexes, the Ets1 and Runx1 fragments contain intrinsically disordered regulatory regions as well as their DNA-binding domains. Crystals of the complex containing unmodified Ets1 belonged to space group P2(1)2(1)2(1), with unit-cell parameters a = 78.7, b = 102.1, c = 195.0 angstrom, and diffracted X-rays to a resolution of 2.35 angstrom, and those containing phosphorylated Ets1 belonged to the same space group, with unit-cell parameters a = 78.6, b = 101.7, c = 194.7 angstrom, and diffracted X-rays to a similar resolution. To facilitate crystallization, a Runx1 residue involved in a hydrophobic patch that was predicted to be engaged in crystal packing based on the previously reported structures of Runx1-containing crystals was mutated.

    DOI: 10.1107/S2053230X14018470

    Web of Science

    PubMed

    researchmap

  • Missense mutations in the DNA-binding/dimerization domain of NFIX cause Sotos-like features Reviewed

    Yuriko Yoneda, Hirotomo Saitsu, Mayumi Touyama, Yoshio Makita, Akie Miyamoto, Keisuke Hamada, Naohiro Kurotaki, Hiroaki Tomita, Kiyomi Nishiyama, Yoshinori Tsurusaki, Hiroshi Doi, Noriko Miyake, Kazuhiro Ogata, Kenji Naritomi, Naomichi Matsumoto

    JOURNAL OF HUMAN GENETICS   57 ( 3 )   207 - 211   2012.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Sotos syndrome is characterized by prenatal and postnatal overgrowth, characteristic craniofacial features and mental retardation. Haploinsufficiency of NSD1 causes Sotos syndrome. Recently, two microdeletions encompassing Nuclear Factor I-X (NFIX) and a nonsense mutation in NFIX have been found in three individuals with Sotos-like overgrowth features, suggesting possible involvements of NFIX abnormalities in Sotos-like features. Interestingly, seven frameshift and two splice site mutations in NFIX have also been found in nine individuals with Marshall-Smith syndrome. In this study, 48 individuals who were suspected as Sotos syndrome but showing no NSD1 abnormalities were examined for NFIX mutations by high-resolution melt analysis. We identified two heterozygous missense mutations in the DNA-binding/dimerization domain of the NFIX protein. Both mutations occurred at evolutionally conserved amino acids. The c.179T > C (p.Leu60Pro) mutation occurred de novo and the c.362G > C (p.Arg121Pro) mutation was inherited from possibly affected mother. Both mutations were absent in 250 healthy Japanese controls. Our study revealed that missense mutations in NFIX were able to cause Sotos-like features. Mutations in DNA-binding/dimerization domain of NFIX protein also suggest that the transcriptional regulation is abnormally fluctuated because of NFIX abnormalities. In individuals with Sotos-like features unrelated to NSD1 changes, genetic testing of NFIX should be considered. Journal of Human Genetics (2012) 57, 207-211; doi:10.1038/jhg.2012.7; published online 2 February 2012

    DOI: 10.1038/jhg.2012.7

    Web of Science

    PubMed

    researchmap

  • Mutations in POLR3A and POLR3B Encoding RNA Polymerase III Subunits Cause an Autosomal-Recessive Hypomyelinating Leukoencephalopathy Reviewed

    Hirotomo Saitsu, Hitoshi Osaka, Masayuki Sasaki, Jun-ichi Takanashi, Keisuke Hamada, Akio Yamashita, Hidehiro Shibayama, Masaaki Shiina, Yukiko Kondo, Kiyomi Nishiyama, Yoshinori Tsurusaki, Noriko Miyake, Hiroshi Doi, Kazuhiro Ogata, Ken Inoue, Naomichi Matsumoto

    AMERICAN JOURNAL OF HUMAN GENETICS   89 ( 5 )   644 - 651   2011.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    Congenital hypomyelinating disorders are a heterogeneous group of inherited leukoencephalopathies characterized by abnormal myelin formation. We have recently reported a hypomyelinating syndrome characterized by diffuse cerebral hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC). We performed whole-exome sequencing of three unrelated individuals with HCAHC and identified compound heterozygous mutations in POLR3B in two individuals. The mutations include a nonsense mutation, a splice-site mutation, and two missense mutations at evolutionally conserved amino acids. Using reverse transcription-PCR and sequencing, we demonstrated that the splice-site mutation caused deletion of exon 18 from POLR3B mRNA and that the transcript harboring the nonsense mutation underwent nonsense-mediated mRNA decay. We also identified compound heterozygous missense mutations in POLR3A in the remaining individual. POLR3A and POLR3B encode the largest and second largest subunits of RNA Polymerase III (Pol III), RPC1 and RPC2, respectively. RPC1 and RPC2 together form the active center of the polymerase and contribute to the catalytic activity of the polymerase. Pol III is involved in the transcription of small noncoding RNAs, such as SS ribosomal RNA and all transfer RNAs (tRNA). We hypothesize that perturbation of Pal 111 target transcription, especially of tRNAs, could be a common pathological mechanism underlying POLR3A and POLR3B mutations.

    DOI: 10.1016/j.ajhg.2011.10.003

    Web of Science

    PubMed

    researchmap

  • Rational Approach to the Synthesis, Evaluation, and Ga-68 Labeling of a Novel 4-Anilinoquinoline Epidermal Growth Factor Receptor Inhibitor as a New Imaging Agent That Selectively Targets the Epidermal Growth Factor Receptor Tyrosine Kinase Reviewed

    Chumpol Theeraladanon, Nobukazu Takahashi, Masaaki Shiina, Keisuke Hamada, Yuuki Takada, Hisashi Endo, Ukihide Tateishi, Takashi Oka, Kazuhiro Ogata, Tomio Inoue

    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS   25 ( 4 )   479 - 485   2010.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MARY ANN LIEBERT INC  

    Certain small-molecule inhibitors that target epidermal growth factor receptor (EGFR), such as Gefitinib, Erlotinib, and Lapatinib, provide a new approach for cancer treatment. In accordance with the pharmacophore model for inhibitor competition at EGFR-binding site, this study proposes a rationalized design for a novel 4-anilinoquinoline EGFR tyrosine kinase inhibitor, [6,7-dimethoxyethoxy]-quinolin-4-yl]-(3-ethynylphenyl)-amine (YCU07). This is the first study to apply ring-closing metathesis toward synthesis of the quinoline nucleus for this 4-anilinoquinoline EGFR inhibitor. YCU07 expressed significant inhibitory activity for EGFR tyrosine kinase in A431 cells, as confirmed by an ABTS microwell peroxidase substrate system read colorimetrically at 405 nm. Injection of Ga-68-labeled glutamic acid polypeptide (GAP)-YCU07 conjugate in nude mice implanted with A431 was imaged by animal PET camera (LabPET8; Gamma Medica-Ideas) and computed tomography (eXplore Locus; GE Healthcare), to evaluate its biodistribution. Ga-68-GAP-YCU accumulated in the receptor-positive tumors, with uptake values of 1.50% +/- 0.09% and 2.36% +/- 0.36% of injected activity per gram tissue at 30 and 90 minutes, respectively.

    DOI: 10.1089/cbr.2009.0614

    Web of Science

    PubMed

    researchmap

  • Dominant-Negative Mutations in alpha-II Spectrin Cause West Syndrome with Severe Cerebral Hypomyelination, Spastic Quadriplegia, and Developmental Delay Reviewed

    Hirotomo Saitsu, Jun Tohyama, Tatsuro Kumada, Kiyoshi Egawa, Keisuke Hamada, Ippei Okada, Takeshi Mizuguchi, Hitoshi Osaka, Rie Miyata, Tomonori Furukawa, Kazuhiro Haginoya, Hideki Hoshino, Tomohide Goto, Yasuo Hachiya, Takanori Yamagata, Shinji Saitoh, Toshiro Nagai, Kiyomi Nishiyama, Akira Nishimura, Noriko Miyake, Masayuki Komada, Kenji Hayashi, Syu-ichi Hirai, Kazuhiro Ogata, Mitsuhiro Kato, Atsuo Fukuda, Naomichi Matsumoto

    AMERICAN JOURNAL OF HUMAN GENETICS   86 ( 6 )   881 - 891   2010.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:CELL PRESS  

    A de novo 9q33.3-q34.11 microdeletion involving STX8P1 has been found in one of four individuals (group A) with early-onset West syndrome, severe hypomyelination, poor visual attention, and developmental delay. Although haploinsufficiency of STXBP1 was involved in early infantile epileptic encephalopathy in a previous different cohort study (group B), no mutations of SIXBP1 were found in two of the remaining three subjects of group A (one was unavailable), We assumed that another gene within the deletion might contribute to the phenotype of group A. SPTAN1 encoding alpha-II spectrin, which is essential for proper myelination in zebratish, turned out to be deleted. In two subjects, an in-frame 3 bp deletion and a 6 bp duplication in SHAN1 were found at the initial nucleation site of the alpha/beta spectrin heterodimer. SPTAN1 was further screened in six unrelated individuals with WS and hypomyelination, but no mutations were found. Recombinant mutant (mut) and wild-type (WT) alpha-II spectrin could assemble heterodimers with beta-II spectrin, but alpha-II (mut)/beta-II spectrin heterodimers were thermolabile compared with the alpha-II (WT)/beta-II heterodimers. Transient expression in mouse cortical neurons revealed aggregation of alpha-II (mut)/beta-II and alpha-II (mut)/beta-III spectrin heterodimers, which was also observed in lymphoblastoid cells from two subjects with in-frame mutations. Clustering of ankyrinG and voltage-gated sodium channels at axon initial segment (AIS) was disturbed in relation to the aggregates, together with an elevated action potential threshold. These findings suggest that pathological aggregation of alpha/beta spectrin heterodimers and abnormal AIS integrity resulting from SPTAN1 mutations were involved in pathogenesis of infantile epilepsy.

    DOI: 10.1016/j.ajhg.2010.04.013

    Web of Science

    PubMed

    researchmap

  • The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b Reviewed

    Kazunari Yamashita, Atsushi Suzuki, Yoshinori Satoh, Mariko Idea, Yoshiko Amano, Maki Masuda-Hirata, Yukiko K. Hayashi, Keisuke Hamada, Kazuhiro Ogata, Shigeo Ohno

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   391 ( 1 )   812 - 817   2010.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Utrophin is a widely expressed paralogue of dystrophin, the protein responsible for Duchenne muscular dystrophy. Utrophin is a large spectrin-like protein whose C-terminal domain mediates anchorage to a laminin receptor. dystroglycan (DG) The rod domain, composed of 22 spectrin-like repeats, connects the N-terminal acrin-binding domain and the C-terminal DG binding domain, and thus mediates molecular linkage between intracellular F-actin and extracellular basement membrane. Previously, we demonstrated that a cell polanty-regulating kinase, PAR-1b. interacts with the utrophin-DG complex, and positively regulates the interaction between Utrophin and DG In this study. we demonstrate that the 8th and 9th spectrin-like repeats (R8 and R9) of utrophin cooperatively form a PAR-1b-interacting domain, and that Ser1258 within R9 is specifically phosphorylated by PAR-1b Substitution of Ser1258 to alanine reduces the interaction between utrophin and DG, suggesting that the Ser1258 phosphorylation contributes to the stabilization of the utrophin-DG complex. Interestingly, PAR-1b also binds and phosphorylates R8-9 of dystrophin, and colocalizes with clystrophin at the skeletal muscle membrane These results reveal a novel function of the rod domain of utrophin beyond that of a passive structural linker connecting the N- and C-terminal domain (C) 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2009.11.144

    Web of Science

    PubMed

    researchmap

  • De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy Reviewed

    Hirotomo Saitsu, Mitsuhiro Kato, Takeshi Mizuguchi, Keisuke Hamada, Hitoshi Osaka, Jun Tohyama, Katsuhisa Uruno, Satoko Kumada, Kiyomi Nishiyama, Akira Nishimura, Ippei Okada, Yukiko Yoshimura, Syu-ichi Hirai, Tatsuro Kumada, Kiyoshi Hayasaka, Atsuo Fukuda, Kazuhiro Ogata, Naomichi Matsumoto

    NATURE GENETICS   40 ( 6 )   782 - 788   2008.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Early infantile epileptic encephalopathy with suppression-burst (EIEE), also known as Ohtahara syndrome, is one of the most severe and earliest forms of epilepsy(1). Using array-based comparative genomic hybridization, we found a de novo 2.0-Mb microdeletion at 9q33.3-q34.11 in a girl with EIEE. Mutation analysis of candidate genes mapped to the deletion revealed that four unrelated individuals with EIEE had heterozygous missense mutations in the gene encoding syntaxin binding protein 1 (STXBP1). STXBP1 (also known as MUNC18-1) is an evolutionally conserved neuronal Sec1/Munc-18 (SM) protein that is essential in synaptic vesicle release in several species(2-4). Circular dichroism melting experiments revealed that a mutant form of the protein was significantly thermolabile compared to wild type. Furthermore, binding of the mutant protein to syntaxin was impaired. These findings suggest that haploinsufficiency of STXBP1 causes EIEE.

    DOI: 10.1038/ng.150

    Web of Science

    PubMed

    researchmap

  • Structural basis for recruitment of human flap endonuclease 1 to PCNA Reviewed

    S Sakurai, K Kitano, H Yamaguchi, K Hamada, K Okada, K Fukuda, M Uchida, E Ohtsuka, H Morioka, T Hakoshima

    EMBO JOURNAL   24 ( 4 )   683 - 693   2005.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:NATURE PUBLISHING GROUP  

    Flap endonuclease- 1 ( FEN1) is a key enzyme for maintaining genomic stability and replication. Proliferating cell nuclear antigen ( PCNA) binds FEN1 and stimulates its endonuclease activity. The structural basis of the FEN1 PCNA interaction was revealed by the crystal structure of the complex between human FEN1 and PCNA. The main interface involves the C- terminal tail of FEN1, which forms two beta- strands connected by a short helix, the betaA -alphaA -betaB motif, participating in beta-beta and hydrophobic interactions with PCNA. These interactions are similar to those previously observed for the p21(CIP1/ WAF1) peptide. However, this structure involving the full- length enzyme has revealed additional interfaces that are involved in the core domain. The interactions at the interfaces maintain the enzyme in an inactive ' locked- down' orientation and might be utilized in rapid DNA- tracking by preserving the central hole of PCNA for sliding along the DNA. A hinge region present between the core domain and the C- terminal tail of FEN1 would play a role in switching the FEN1 orientation from an inactive to an active orientation.

    DOI: 10.1038/sj.emboj.7600519

    Web of Science

    PubMed

    researchmap

  • Crystal structure of the protein histidine phosphatase SixA in the multistep His-Asp phosphorelay Reviewed

    K Hamada, M Kato, T Shimizu, K Ihara, T Mizuno, T Hakoshima

    GENES TO CELLS   10 ( 1 )   1 - 11   2005.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL PUBLISHING LTD  

    The multiple histidine-aspartate phosphorelay system plays a crucial role in cellular adaptation to environments in microorganisms and plants. Like kinase-phosphatase systems in higher eukaryotes, the multiple steps provide additional regulatory checkpoints with phosphatases. The Escherichia coli phosphatase SixA exhibits protein phosphatase activity against the histidine-containing phosphotransfer (HPt) domain located in the C-terminus of the histidine kinase ArcB engaged in anaerobic responses. We have determined the crystal structures of the free and tungstate-bound forms of SixA at 2.06 Angstrom and 1.90 Angstrom resolution, respectively. The results provide the first three-dimensional view of a bacterial protein histidine phosphatase, revealing a compact alpha/beta architecture related to a family of phosphatases containing the arginine-histidine-glycine (RHG) motif at their active sites. Compared with these RHG phosphatases, SixA lacks an extra alpha-helical subdomain as a lid over the active site, thereby forming a relatively shallow groove important for the accommodation of the HPt domain of ArcB. The tungstate ion, which mimics the substrate phosphate group, is located at the centre of the active site where the active residue, His8, points to the tungsten atom in the mode of in-line nucleophilic attack.

    DOI: 10.1111/j.1365-2443.2005.00817.x

    Web of Science

    PubMed

    researchmap

  • Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer Reviewed

    Y Hisanaga, H Ago, N Nakagawa, K Hamada, K Ida, M Yamamoto, T Hori, Y Arii, M Sugahara, S Kuramitsu, S Yokoyama, M Miyano

    JOURNAL OF BIOLOGICAL CHEMISTRY   279 ( 30 )   31717 - 31726   2004.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Long chain fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of long chain fatty acyl-CoA esters. We report the first crystal structures of long chain fatty acyl-CoA synthetase homodimer (LC-FACS) from Thermus thermophilus HB8 (ttLC-FACS), including complexes with the ATP analogue adenosine 5'-(beta,gamma-imido) triphosphate (AMP-PNP) and myristoyl-AMP. ttLC-FACS is a member of the adenylate forming enzyme superfamily that catalyzes the ATP-dependent acylation of fatty acid in a two-step reaction. The first reaction step was shown to propagate in AMP-PNP complex crystals soaked with myristate solution. Myristoyl-AMP was identified as the intermediate. The AMP-PNP and the myristoyl-AMP complex structures show an identical closed conformation of the small C-terminal domains, whereas the uncomplexed form shows a variety of open conformations. Upon ATP binding, the fatty acid-binding tunnel gated by an aromatic residue opens to the ATP-binding site. The gated fatty acid-binding tunnel appears only to allow one-way movement of the fatty acid during overall catalysis. The protein incorporates a hydrophobic branch from the fatty acid-binding tunnel that is responsible for substrate specificity. Based on these high resolution crystal structures, we propose a unidirectional Bi Uni Uni Bi Ping-Pong mechanism for the two-step acylation by ttLC-FACS.

    DOI: 10.1074/jbc.M400100200

    Web of Science

    PubMed

    researchmap

  • Oxyanion hole-stabilized stereospecific isomerization in ribose-5-phosphate isomerase (Rpi) Reviewed

    K Hamada, H Ago, M Sugahara, Y Nodake, S Kuramitsu, M Miyano

    JOURNAL OF BIOLOGICAL CHEMISTRY   278 ( 49 )   49183 - 49190   2003.12

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Ribose-5-phosphate isomerase (Rpi) acts as a key enzyme in the oxidative and reductive pentose-phosphate pathways for the conversion of ribose-5-phosphate (R5P) to ribulose-5-phosphate and vice versa. We have determined the crystal structures of Rpi from Thermus thermophilus HB8 in complex with the open chain form of the substrate R5P and the open chain form of the C2 epimeric inhibitor arabinose-5-phosphate as well as the apo form at high resolution. The crystal structures of both complexes revealed that these ring-opened epimers are bound in the active site in a mirror symmetry binding mode. The O1 atoms are stabilized by an oxyanion hole composed of the backbone amide nitrogens in the conserved motif. In the structure of the Rpi . R5P complex, the conversion moiety O1-C1-C2-O2 in cis-configuration interacts with the carboxyl oxygens of Glu-108 in a water-excluded environment. Furthermore, the C2 hydroxyl group is presumed to be highly polarized by short hydrogen bonding with the side chain of Lys-99. R5P bound as the ring-opened reaction intermediate clarified the high stereoselectivity of the catalysis and is consistent with an aldose-ketose conversion by Rpi that proceeds via a cis-enediolate intermediate.

    DOI: 10.1074/jbc.M309272200

    Web of Science

    PubMed

    researchmap

  • Preparation and crystallization of human flap endonuclease FEN-1 in complex with proliferating-cell nuclear antigen, PCNA Reviewed

    S Sakurai, K Kitano, K Okada, K Hamada, H Morioka, T Hakoshima

    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY   59 ( Pt 5 )   933 - 935   2003.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL MUNKSGAARD  

    Flap endonuclease-1 (FEN-1) is a structure-specific nuclease that removes 5'-overhanging flaps in DNA repair and replication. FEN-1 binds proliferating-cell nuclear antigen (PCNA), a DNA-clamp protein, when processing Okazaki fragments during lagging-strand DNA synthesis. Here, the crystallization of the complex between human FEN-1 and PCNA is reported. The crystals were found to belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 82.2, b = 143.4, c = 246.7 Angstrom, and contained one complex in the crystallographic asymmetric unit. A diffraction data set was collected to a resolution of 3.0 Angstrom.

    DOI: 10.1107/S0907444903004815

    Web of Science

    PubMed

    researchmap

  • Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex Reviewed

    K Hamada, T Shimizu, S Yonemura, S Tsukita, S Tsukita, T Hakoshima

    EMBO JOURNAL   22 ( 3 )   502 - 514   2003.2

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    ERM (ezrin/radixin/moesin) proteins recognize the cytoplasmic domains of adhesion molecules in the formation of the membrane-associated cytoskeleton. Here we report the crystal structure of the radixin FERM (4.1 and ERM) domain complexed with the ICAM-2 cytoplasmic peptide. The non-polar region of the ICAM-2 peptide contains the RxxTYxVxxA sequence motif to form a beta-strand followed by a short 3(10)-helix. It binds the groove of the phosphotyrosine-binding (PTB)-like subdomain C mediated by a beta-beta association and several side-chain interactions. The binding mode of the ICAM-2 peptide to the FERM domain is distinct from that of the NPxY motif-containing peptide binding to the canonical PTB domain. Mutation analyses based on the crystal structure reveal the determinant elements of recognition and provide the first insights into the physical link between adhesion molecules and ERM proteins.

    DOI: 10.1093/emboj/cdg039

    Web of Science

    PubMed

    researchmap

  • Structural basis for neurofibromatosis type 2 - Crystal structure of the merlin FERM domain Reviewed

    T Shimizu, A Seto, N Maita, K Hamada, S Tsukita, S Tsukita, T Hakoshima

    JOURNAL OF BIOLOGICAL CHEMISTRY   277 ( 12 )   10332 - 10336   2002.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Neurofibromatosis type 2 (NF2) is a dominantly inherited disease associated with the central nervous system. The NF2 gene product merlin is a tumor suppressor, and its mutation or inactivation causes this disease. We report here the crystal structure of the merlin FERM domain containing a 22-residue alpha-helical segment. The structure reveals that the merlin FERM domain consists of three subdomains displaying notable features of the electrostatic surface potentials, although the overall surface potentials similar to those of ezrin/radixin/moesin (ERM) proteins indicate electrostatic membrane association. The structure also is consistent with inactivation mechanisms caused by the pathogenic mutations associated with NF2.

    DOI: 10.1074/jbc.M109979200

    Web of Science

    PubMed

    researchmap

  • Crystallization and preliminary crystallographic studies of RhoGDI in complex with the radixin FERM domain Reviewed

    K Hamada, A Seto, T Shimizu, MB Takeshi, Y Takai, S Tsukita, S Tsukita, T Hakoshima

    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY   57 ( Pt 6 )   889 - 890   2001.6

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MUNKSGAARD INT PUBL LTD  

    The Rho guanine nucleotide-dissociation inhibitor (RhoGDI) is a general regulator that forms a complex with the GDP-bound form of Rho-family GTPases and suppresses their activation. The FERM domains of ERM (ezrin/radixin/moesin) proteins bind to RhoGDI and dissociate Rho from RhoGDI. The formation of a complex between RhoGDI and the FERM domain is an important step in the regulatory cycle of Rho activation. In this study, crystals of RhoGDI complexed with the FERM domain of radixin were obtained. The crystals of the binary complex belong to the space group P2(1)2(1)2, with unit-cell parameters a = 130.9 (2), b = 151.2 (2), c = 71.2 (1) Angstrom, and contain two protein complexes in the crystallographic asymmetric unit. A 2.9 Angstrom resolution data set was collected using synchrotron radiation at SPring-8.

    DOI: 10.1107/S090744490100556X

    Web of Science

    PubMed

    researchmap

  • Crystallographic characterization of the radixin FERM domain bound to the cytoplasmic tail of the adhesion protein ICAM-2 Reviewed

    K Hamada, T Shimizu, T Matsui, S Tsukita, S Tsukita, T Hakoshima

    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY   57 ( Pt 6 )   891 - 892   2001.6

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MUNKSGAARD INT PUBL LTD  

    Radixin is a member of the ERM proteins, which cross-link plasma membranes and actin filaments. The FERM domains located at the N-terminal regions of ERM proteins are responsible for membrane association through direct interactions with the cytoplasmic domains of integral membrane proteins. Here, crystals of the complex between the radixin FERM domain and the full-length cytoplasmic tail (28-residue peptide) of intercellular adhesion molecule 2, ICAM-2, have been obtained. The crystals were found to belong to space group P3(1)21 or P3(2)21, with unit-cell parameters a = b = 100.44 (9), c = 99.49 (6) Angstrom, and contain one complex in the crystallographic asymmetric unit. An intensity data set was collected to a resolution of 2.60 Angstrom.

    DOI: 10.1107/S0907444901005716

    Web of Science

    PubMed

    researchmap

  • Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain Reviewed

    K Hamada, T Shimizu, T Matsui, S Tsukita, S Tsukita, T Hakoshima

    EMBO JOURNAL   19 ( 17 )   4449 - 4462   2000.9

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    Radixin is a member of the ezrin/radixin/moesin (ERM) family of proteins, which play a role in the formation of the membrane-associated cytoskeleton by linking actin filaments and adhesion proteins. This cross-linking activity is regulated by phosphoinositides such as phosphatidylinositol 4,5-bisphosphate (PIP2) in the downstream of the small G protein Rho, The X-ray crystal structures of the radixin FERM domain, which is responsible for membrane binding, and its complex with inositol-(1,4,5)-trisphosphate (IP3) have been determined. The domain consists of three subdomains featuring a ubiquitin-like fold, a four-helix bundle and a phosphotyrosine-binding-like domain, respectively. These subdomains are organized by intimate interdomain interactions to form characteristic grooves and clefts. One such groove is negatively charged and so is thought to interact with basic juxta-membrane regions of adhesion proteins. IP3 binds a basic cleft that is distinct from those of pleckstrin homology domains and is located on a positively charged flat molecular surface, suggesting an electrostatic mechanism of plasma membrane targeting. Based on the structural changes associated with IP3 binding, a possible unmasking mechanism of ERM proteins by PIP2 is proposed.

    DOI: 10.1093/emboj/19.17.4449

    Web of Science

    PubMed

    researchmap

  • Crystallographic characterization of the membrane-binding domain of radixin Reviewed

    K Hamada, T Matsui, S Tsukita, S Tsukita, T Hakoshima

    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY   56 ( Pt 7 )   922 - 923   2000.7

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MUNKSGAARD INT PUBL LTD  

    Radixin is a protein which cross-links plasma membranes and actin filaments and thus forms membrane-associated cytoskeleton. The radixin N-terminal domain, which is responsible for membrane association, has been purified and crystallized by vapour diffusion with polyethylene glycol 6000. The crystals belong to space group P4(1)2(1)2 or P4(3)2(1)2, with unit-cell parameters a = b = 96.36, c = 133.16 Angstrom, and diffract to a resolution of 3.0 Angstrom.

    DOI: 10.1107/S0907444900006363

    Web of Science

    PubMed

    researchmap

  • Crystallographic characterization of a novel protein SixA which exhibits phospho-histidine phosphatase activity in the multistep His-Asp phosphorelay Reviewed

    K Hamada, M Kato, T Mizuno, T Hakoshima

    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY   55 ( Pt 1 )   269 - 271   1999.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MUNKSGAARD INT PUBL LTD  

    SixA has been isolated from Escherichia coli as the first protein to exhibit phospho-histidine phosphatase activity. Recent biochemical studies have shown that SixA is involved in the signal transduction of the His-Asp phosphorelay through the dephosphorylation of the histidine-containing phosphotransfer (HPt) domain of the anaerobic sensor kinase ArcB. Crystals of SixA were obtained using a hanging-drop vapour-diffusion method with polyethylene glycol and calcium ions. Preliminary X-ray crystallographic analysis revealed that the crystals belonged to space group P2(1)2(1)2(1) with unit-cell dimensions a = 39.26, b = 48.62 and c = 83.18 Angstrom, having one molecule in the crystallographic asymmetric unit. The intensity data were collected up to 1.5 Angstrom resolution using synchrotron radiation.

    DOI: 10.1107/S0907444998007756

    Web of Science

    PubMed

    researchmap

▼display all

MISC

Presentations

  • Structural basis for the substrate recognition of a peptide histidine prenyltransferase

    Keisuke Hamada, Yuchen Zhang, Dinh Thanh Nguyen, Sumika Inoue, Masayuki Satake, Shunsuke Kobayashi, Chikako Okada, Masahiro Okada, Yuki Goto, Hiroaki Suga, Kazuhiro Ogata, Toru Sengoku

    Annual Meeting of the Protein Science Society of Japan  2022.6 

     More details

    Event date: 2022.6

    Language:English   Presentation type:Oral presentation (general)  

    researchmap

  • ヒストンシャペロンNap1の構造解析

    浜田恵輔, 椎名政昭, 中島理沙, 斎藤誠, 伊藤敬, 緒方一博

    日本生化学会年会  2014.10 

     More details

  • トリプトファンプレニル基転移酵素の結晶構造解析

    濱田恵輔, 岡田千佳子, 井上澄香, 後藤佑樹, 菅裕明, 緒方一博, 仙石徹

    日本生化学会年会  2019.9 

     More details

  • 酸化ストレス応答に関わるCNCファミリー転写因子Nrf2による転写制御の立体構造基盤

    濱田 恵輔, 仙石 徹, 椎名 政昭, 鈴木 香絵, 佐藤 光, 内山 晃子, 小林 俊介, 小國 麻子, 板谷 颯人, 笠原 浩太, 森脇 寛智, 渡邉 千鶴, 本間 光貴, 岡田 千佳子, 馬場 しほ, 太田 力, 本橋 ほづみ, 山本 雅之, 緒方 一博

    日本組織培養学会  2024.6 

     More details

Research Projects

  • ペプチド創薬に応用可能なペプチドプレニル基転移酵素群の構造生物学的解析

    Grant number:24K09355  2024.4 - 2027.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    浜田 恵輔

      More details

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    researchmap

  • トリプトファンプレニル基転移酵素のペプチド基質認識と反応機構の構造学的解明

    Grant number:21K06051  2021.4 - 2024.3

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    浜田 恵輔, 仙石 徹, 緒方 一博

      More details

    Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )

    ペプチド創薬においてペプチドの膜透過性やプロテアーゼ耐性をいかに付与するかが課題となっている。プレニル基転移酵素によるペプチドのプレニル化はその解決法の一つに挙げられる。しかし、酵素の基質認識機構や反応機構の理解が十分進んでいないため、リード化合物検索に用いるプレニル化ペプチドライブラリーの構築に対する妨げになっている。
    微生物由来の酵素KgpFや酵素X(未発表のため仮名とする)はペプチド中のトリプトファンを基質とし、膜透過性向上が期待されるプレニル化ピロロインドリンを生成する。興味深いことに、これらの酵素は互いに異なる基質選択性をもち、立体化学的に異なる生成物を作り分ける。本研究では、分子構造解析により両酵素の基質特異性、反応機構を解明する。これらの知見は効率的なライブラリーのデザインを可能にし、また酵素の合理的改変を通じて多様性に富んだ次世代ライブラリーを構築するための基盤を与える。
    本研究では、トリプトファンプレニル基転移酵素であるKgpF (および酵素X)による基質認識の構造基盤を明らかにすることを目的として、酵素-プレニル基供与体アナログ(ジメチルアリルチオ二リン酸、DMASPP)-基質ペプチド複合体のX線結晶構造解析を推進した。
    これまでに酵素Xにおいては、5残基からなる活性上最適な基質ペプチドを用いて、酵素X-DMASPP-基質ペプチド複合体の結晶化に成功し、X線結晶構造解析を1.5Å分解能で行った。その結果、基質ペプチドのトリプトファンインドール環のNH基は類縁酵素間でよく保存され触媒に必須なグルタミン酸残基と水素結合を形成し認識されていた。また、このインドール環は、類縁酵素間で保存性が低い複数の残基とのファンデルワールス接触により認識されることが明らかになった。

    researchmap

  • Study of the mechanism of nucleosome-enhanceosome conversion

    Grant number:18K19305  2018.6 - 2021.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Challenging Research (Exploratory)  Grant-in-Aid for Challenging Research (Exploratory)

    OGATA Kazuhiro

      More details

    Grant amount:\6370000 ( Direct Cost: \4900000 、 Indirect Cost:\1470000 )

    Histone-modifying enzymes play an important role in the nucleosome-enhanceosome structural remodeling associated with transcriptional activation. In this study, we determined the three-dimensional structure of NSD2, a histone methyltransferase that dimethylated lysine 36 of histone H3 (H3K36), in complex with a nucleosome substrate by single-particle analysis using cryo-electron microscopy. In the absence of a nucleosome, NSD2 is inactive due to the binding of the autoinhibitory loop. However, in our structure, NSD2 bound to nucleosome coordinates the conformational change of the autoinhibitory loop and the dissociation of DNA from the nucleosome, resulting in the methylation of H3K36. In addition, the oncogenic variants of NSD2 destabilize the autoinhibitory loop, making the enzyme unable to maintain its inhibitory state.

    researchmap

  • Search for anti-leukemic drugs targeting the cancer-related transcription factor Runx1/CBFbeta

    Grant number:16H03293  2016.4 - 2019.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    Ogata Kazuhiro

      More details

    Grant amount:\18850000 ( Direct Cost: \14500000 、 Indirect Cost:\4350000 )

    The molecule targeted therapy has been shown to be effective against various cancers. One of the potential targets is a transcription factor because its mutation is known to be frequently involved in cancer development. However, few drugs targeting transcription factors have been available. We have aimed to develop anti-leukemic drugs targeting a transcription factor, Runx1. Runx1 is a master regulator of the blood cell development, and various mutations of Runx1 gene have frequently been found in acute myelogenous leukemia (AML) patients.
    We have searched for compounds that could destabilize the regulatory region of Runx1-DNA binding based on the molecular structure, and verified that some compounds have an ability to bind to Runx1 and inhibit DNA binding of Runx1. Furthermore, we have shown that these compounds could inhibit the transcriptional activation ability of Runx1 and decrease the cell-survival rate for the Kasumi-1 AML cells with the Runx1 mutation.

    researchmap

  • Regulation mechanism of a transcription cycle by static/dynamic structural analyses

    Grant number:24118005  2012.6 - 2017.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)  Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)

    OGATA Kazuhiro, SHIINA Masaaki, HAMADA Keisuke

      More details

    Grant amount:\122330000 ( Direct Cost: \94100000 、 Indirect Cost:\28230000 )

    Signal transduction transfers cellular environmental information to nucleus via chemical modifications of proteins and finally modulates transcription profile of the cell. To reveal the molecular mechanism of conversion of the information from chemical modification to transcriptional modulation, we employed static and dynamic structural analyses of higher-ordered transcription factors(TF)-DNA complexes. We found that phosphorylation of the intrinsically disordered region of the transcription factor Ets1 induces a non-DNA-binding conformer of Ets1 itself. On the tcrα enhancer, the partner TF Runx1 selects the specific Ets1 conformer that is refractory to effect of phosphorylation, resisting the inhibitory effect of phosphorylation of Ets1 and specifically keeping the tcrα gene transcription active, while many of other Ets1-target genes turn off. This transcription switch may enable fine regulation responding to cellular environments including development and proliferation signals.

    researchmap

  • Study for molecular mechanisms of chromatin remodeling factors

    Grant number:19770089  2007 - 2008

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B)  Grant-in-Aid for Young Scientists (B)

    HAMADA Keisuke

      More details

    Grant amount:\3840000 ( Direct Cost: \3300000 、 Indirect Cost:\540000 )

    researchmap

  • Mechanism for regulation of DECODE complexes in gene activation

    Grant number:17054033  2005 - 2009

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research on Priority Areas  Grant-in-Aid for Scientific Research on Priority Areas

    OGATA Kazuhiro, SHIINA Masaaki, HAMADA Keisuke, SATO Ko

      More details

    Grant amount:\105600000 ( Direct Cost: \105600000 )

    Multiple transcription factors (TFs) regulate transcription by forming TFs-DNA complexes. A cell signaling causes chemical modification of transcription factors, which modulates transcriptional activities. Besides, effect of chemical modification of transcription factors on their activity in the context of TFs-DNA complexes, however, is largely unknown. In this sturdy, we showed that the phosphorylation of a transcription factor Ets1 "differentially" modulates Ets1-containing TFs-DNA complexes. In addition, we clarified the underlying mechanism by which the selective modulation of Ets1-containing TFs-DNA complexes is achieved using NMR analyses of allosteric regulation of Runx1 by CBFβ and crystallographic analyses of multiprotein-DNA complex comprised of Ets1, Runx1 and CBFβ formed on the TCRα gene enhancer.

    researchmap

  • 膜結合型グルタチオンS-トランスフェラーゼの結晶構造解析

    Grant number:16770086  2004 - 2006

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    浜田 恵輔

      More details

    Grant amount:\3700000 ( Direct Cost: \3700000 )

    細胞膜結合型グルタチオン転移酵素(microsomal gluthathione S-transferase ; MGST)は、細胞内異物に対する解毒作用や脂肪の酸敗の主因である脂質ヒドロペルオキシドに対する還元作用のほか、アラキドン酸カスケードで合成される生理活性物質であるロイコトリエンやプロスタグランジンE2の合成を触媒する機能を併せ持つことが知られている。MGSTは喘息や炎症に対する薬剤ターゲットになる可能性があるため、その立体構造は薬剤探索において重要な情報を与える。本研究では、MGSTのX線結晶構造解析を行い、立体構造と機能解析から酵素活性機構の解明を目指す。
    これまでに、マウス由来のMGST1について、大腸菌によるタンパク質発現系を構築し、タンパク質の安定化のための界面活性剤の探索を含めた精製法の検討を行い、結晶化条件の探索を行った。さらに、従来法のほか立方液晶相を利用しての結晶化の検討を行った。その結果、全長MGSTについて結晶の析出がみられたが、X線回折実験の結果から、結晶は低分解能の反射しか与えず、現段階では構造解析には至っていない。同結晶の結晶化条件の最適化やアニーリング、デハイドレーション等の操作による分解能の向上や回折異方性の軽減を試みた。MGSTは広い基質特異性をもつことが知られており、グルタチオンを含めた酵素一基質類似体との複合体の調製を行い、複合体の安定性の検討および結晶化条件の検索を行っている。

    researchmap

  • Study of molecular structural and dynamical aspects of transcriptional regulatory factors

    Grant number:16370051  2004 - 2005

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (B)  Grant-in-Aid for Scientific Research (B)

    OAGATA Kazuhiro, SATO Ko, SHIINA Masaaki, HAMADA Keisuke

      More details

    Grant amount:\15300000 ( Direct Cost: \15300000 )

    The goal of this project is to elucidate molecular mechanisms for regulating the enhanceosome formation, particularly, stabilization of transcription factors bound to an enhancer region of a gene.
    We investigated some complexes containing a transcriptional regulatory factor, Runx1, which plays a pivotal role in hematopoiesis and is involved in acute leukemias. The DNA binding activity of Runxl is enhanced allosterically by non-DNA binding heterodimeric partner, CBFβ. Previously, we showed that there was no significant structural change of Runxl upon binding of CBFβ when a crystal structure of Runx1-DNA complex was compared with that of Runx1-CBFβ-DNA complex. It promoted us to focus on molecular fluctuations of Runx1. Magnetic relaxation measurements using NMR demonstrated that some regions of Runx1 are significantly fluctuated without CBFβ, while the fluctuations of Runx1 became reduced upon binding of CBFβ. We proposed that regulations of molecular functions are accomplished by altering molecular fluctuations.
    Runxl is also involved in transcriptional regulation of the T cell antigen receptor a chain (TCRα) together with another transcriptional regulatory factor, Etsl. The DNA binding activity of Etsl is controlled by an N-terminal flanking region of ETS domain, referred exon VII. The exon VII inhibits the DNA binding activity of Ets1 while the inhibition is released by an adjacently placed Runxl. Etsl is not capable of binding the enhancer upon phosphorylation of exon VII even if Runxl binds to the enhancer. We investigated the molecular details of the complex composed of Runxl and Etsl in the TCRα enhancer using X-ray crystallography, EMSA and the luciferase reporter gene assay. We identified which regions of Etsl are responsible for cooperative DNA binding with Runxl and the impact of the exon VII phosphorylation. Further structural analyses might be required to unveil overall aspect of the regulatory systems. We will also study about fluctuations of Runxl upon Etsl binding.

    researchmap

  • 3量体G蛋白質におけるGiαサブユニットの活性制御機構の構造学的研究

    Grant number:14780532  2002 - 2003

    日本学術振興会  科学研究費助成事業 若手研究(B)  若手研究(B)

    浜田 恵輔

      More details

    Grant amount:\3500000 ( Direct Cost: \3500000 )

    3量体G蛋白質はGαとGβγで構成され、G蛋白質共役型受容体(GPCR)から標的蛋白質へ多様なシグナル伝達を行う。Gαの活性化(GTP結合型)と不活性化(GDP結合型)の切り替えの機構には幾つかの制御蛋白質が関与する。従来、Gαに対してGPCRはGEF(GDP/GTP exchange factor)、RGSファミリーはGAP(GTPase activating protein)、GβγはGDI(GDP dissociation inhibitor)として働く。最近、GDP結合型Gαに特異的に結合するGolocoモチーフを有する一群の蛋白質がGαからGDPの解離を抑制するとともに、Gαを細胞質に留まらせるというGDIとして機能することが知られるようになった。
    LGN(677アミノ酸)はC末端側に4つのGoLocoモチーフをもつGiα結合蛋白質であり、細胞分裂時における細胞の非対称性の維持や染色体分離に関与する。本研究では、GDPが結合した。GiαとLGNあるいはGoLocoモチーフとの複合体のX線結晶構造解析を行い、GoLocoモチーフによるGiαの認識およびGDI活性の分子メカニズムを明らかにすること、およびLGNの構造解析を行ってLGNの構造と機能の関係について考察することを目的とした。
    ヒト由来のLGN全長蛋白質とGoloco断片の大腸菌による発現、蛋白質精製法を確立した。LGN全長蛋白質の系にいては、ポリエチレングリコール4000,pH7.0の溶液中において微結晶を得ており、現在、X線回折能の向上を図るため、種々の添加剤を用いて結晶化条件の詳細な検索を行っている。また、位相決定のためセレノメチオニン置換体の作成を行った。GiαとLGN全長およびGoLocoモチーフ断片の複合体の結晶化を広範な溶液条件下で行っている。

    researchmap

  • センサー蛋白質ArcBの全体構造と蛋白質ホスファターゼとの相互作用の構造研究

    Grant number:99J08250  1999 - 2000

    日本学術振興会  科学研究費助成事業 特別研究員奨励費  特別研究員奨励費

    濱田 恵輔

      More details

    Grant amount:\1800000 ( Direct Cost: \1800000 )

    researchmap

▼display all

Teaching Experience

  • Biochemistry Practice

    Institution:Yokohama City University

     More details

  • nucleic acid chemistry

    Institution:Yokohama City University

     More details

  • Protein Chemistry

    Institution:Yokohama City University

     More details